4P-PDOT   

GtoPdb Ligand ID: 1358

Synonyms: 4-phenyl-2-propionamidotetraline | N-(4-phenyltetralin-2-yl)propanamide
Compound class: Synthetic organic
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 29.1
Molecular weight 279.16
XLogP 3.56
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES CCC(=O)NC1Cc2ccccc2C(C1)c1ccccc1
Isomeric SMILES CCC(=O)NC1Cc2ccccc2C(C1)c1ccccc1
InChI InChI=1S/C19H21NO/c1-2-19(21)20-16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,2,12-13H2,1H3,(H,20,21)
InChI Key RCYLUNPFECYGDW-UHFFFAOYSA-N
References
1. Audinot V, Mailliet F, Lahaye-Brasseur C, Bonnaud A, Le Gall A, Amossé C, Dromaint S, Rodriguez M, Nagel N, Galizzi JP et al.. (2003)
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Naunyn Schmiedebergs Arch. Pharmacol., 367 (6): 553-61. [PMID:12764576]
2. Dubocovich ML, Masana MI, Iacob S, Sauri DM. (1997)
Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.
Naunyn Schmiedebergs Arch. Pharmacol., 355 (3): 365-75. [PMID:9089668]
3. Dubocovich ML, Yun K, Al-Ghoul WM, Benloucif S, Masana MI. (1998)
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.
FASEB J., 12 (12): 1211-20. [PMID:9737724]